R&D expense

Recent Articles

RELATED ARTICLES

  1. After a Beijing IPO last year, the loss-making biotech has also filed for a Hong Kong listing to better compete in the crowded market for HPV vaccines.
    Health Guard plans dual listing to fund HPV vaccine fight
  2. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  3. Payment app Lianlian seeks IPO relief from cash crunch
  4. Charged up by new investor BYD, BaTeLab cleared for IPO
  5. Lopal Tech seeks cash after losses balloon with lithium price plunge
  6. Legend Holdings shows diversification isn’t always a winning formula
    3396.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva